![Joseph Luminiello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Luminiello
Vorstandsvorsitzender bei Third Coast Therapeutics, Inc.
Profil
Joseph Luminiello currently works at Ave Maria Biotechnology LLC, as Chief Executive Officer from 2021 and Third Coast Therapeutics, Inc., as Chief Executive Officer.
Aktive Positionen von Joseph Luminiello
Unternehmen | Position | Beginn |
---|---|---|
Third Coast Therapeutics, Inc.
![]() Third Coast Therapeutics, Inc. Medical SpecialtiesHealth Technology Third Coast Therapeutics, Inc. engages in pharmaceutical industry. It offers cancer treatment by developing orally active and small molecule drugs. The company is headquartered in Evanston, IL. | Vorstandsvorsitzender | - |
Ave Maria Biotechnology LLC
![]() Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Vorstandsvorsitzender | 01.08.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Third Coast Therapeutics, Inc.
![]() Third Coast Therapeutics, Inc. Medical SpecialtiesHealth Technology Third Coast Therapeutics, Inc. engages in pharmaceutical industry. It offers cancer treatment by developing orally active and small molecule drugs. The company is headquartered in Evanston, IL. | Health Technology |
Ave Maria Biotechnology LLC
![]() Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Commercial Services |